DOI:
10.1055/s-00000005
Aktuelle Rheumatologie
LinksClose Window
References
Burmester GR, Blanco R, Charles-Schoeman C. et al.
Tofacitinib (CP-690,550) in combination with methotrexate in patients with active rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitors: a randomised phase 3 trial.
Lancet 2013;
381: 451-460
We do not assume any responsibility for the contents of the web pages of other providers.